Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules

National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
hiv-infectionssyntheticvaccines
hiv infections, vaccines, synthetic, hiv envelope protein gp120, aids vaccines, hiv seronegativity, avipoxvirus, hiv preventive vaccine, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 836046
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.